Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Junxian Yu

Showing results (11-20 of 36) with videos related to

Pageof 4
Sort By:
Cancer Biotherapy & Radiopharmaceuticals|June 17, 2017
Molecular Targeted Drugs and Treatment of Colorectal Cancer: Recent Progress and Future PerspectivesFang Geng, Zheng Wang, Hang Yin, et al.
Molecules (Basel, Switzerland)|October 15, 2016
Artemisinin and Its Derivatives as a Repurposing Anticancer Agent: What Else Do We Need to Do?Zhe Li, Qin Li, Jun Wu, et al.
Environmental Toxicology and Pharmacology|May 3, 2016
Inhibitory effects and mechanism of 25-OH-PPD on glomerular mesangial cell proliferation induced by high glucoseJunxian Yu, Chunna Liu, Zhe Li, et al.
Asia-Pacific Journal of Clinical Oncology|May 12, 2023
Efficacy and adverse events of immune checkpoint inhibitors in esophageal cancer patients: Challenges and perspectives for immunotherapyYingjie Ma, Junxian Yu, Xiaoting Ma, et al.
Reproductive Sciences (Thousand Oaks, Calif.)|April 8, 2025
Using Machine Learning to Predict the Prognosis of Cervical Cancer Patients with Lymph Node Metastasis: An Analysis Based on the SEER DatabaseErle Deng, Zheng Gu, Hongtao Wei, et al.
Discover Oncology|March 11, 2025
Research trends and highlights in PD-1/PD-L1 inhibitor immunotherapy in lung cancer: a bibliometric analysisZheng Gu, Erle Deng, Jing Ai, et al.
Plos One|April 20, 2016
Clinical Validation of Therapeutic Drug Monitoring of Imipenem in Spent Effluent in Critically Ill Patients Receiving Continuous Renal Replacement Therapy: A Pilot StudyAiping Wen, Zhe Li, Junxian Yu, et al.
Oncotargets and Therapy|May 23, 2018
Traditional Chinese medicine <i>Astragalus</i> polysaccharide enhanced antitumor effects of the angiogenesis inhibitor apatinib in pancreatic cancer cells on proliferation, invasiveness, and apoptosisJun Wu, Jing Wang, Qiang Su, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|September 27, 2017
Quantitative analysis of necrostatin-1, a necroptosis inhibitor by LC-MS/MS and the study of its pharmacokinetics and bioavailabilityFang Geng, Hang Yin, Zhe Li, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|February 12, 2018
Astragalus polysaccharide enhanced antitumor effects of Apatinib in gastric cancer AGS cells by inhibiting AKT signalling pathwayJun Wu, Junxian Yu, Jing Wang, et al.
Pageof 4

Showing results (11-20 of 36) with videos related to

Sort By:
Pageof 4
Cancer Biotherapy & Radiopharmaceuticals|June 17, 2017
Molecular Targeted Drugs and Treatment of Colorectal Cancer: Recent Progress and Future PerspectivesFang Geng, Zheng Wang, Hang Yin, et al.
Molecules (Basel, Switzerland)|October 15, 2016
Artemisinin and Its Derivatives as a Repurposing Anticancer Agent: What Else Do We Need to Do?Zhe Li, Qin Li, Jun Wu, et al.
Environmental Toxicology and Pharmacology|May 3, 2016
Inhibitory effects and mechanism of 25-OH-PPD on glomerular mesangial cell proliferation induced by high glucoseJunxian Yu, Chunna Liu, Zhe Li, et al.
Asia-Pacific Journal of Clinical Oncology|May 12, 2023
Efficacy and adverse events of immune checkpoint inhibitors in esophageal cancer patients: Challenges and perspectives for immunotherapyYingjie Ma, Junxian Yu, Xiaoting Ma, et al.
Reproductive Sciences (Thousand Oaks, Calif.)|April 8, 2025
Using Machine Learning to Predict the Prognosis of Cervical Cancer Patients with Lymph Node Metastasis: An Analysis Based on the SEER DatabaseErle Deng, Zheng Gu, Hongtao Wei, et al.
Discover Oncology|March 11, 2025
Research trends and highlights in PD-1/PD-L1 inhibitor immunotherapy in lung cancer: a bibliometric analysisZheng Gu, Erle Deng, Jing Ai, et al.
Plos One|April 20, 2016
Clinical Validation of Therapeutic Drug Monitoring of Imipenem in Spent Effluent in Critically Ill Patients Receiving Continuous Renal Replacement Therapy: A Pilot StudyAiping Wen, Zhe Li, Junxian Yu, et al.
Oncotargets and Therapy|May 23, 2018
Traditional Chinese medicine <i>Astragalus</i> polysaccharide enhanced antitumor effects of the angiogenesis inhibitor apatinib in pancreatic cancer cells on proliferation, invasiveness, and apoptosisJun Wu, Jing Wang, Qiang Su, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|September 27, 2017
Quantitative analysis of necrostatin-1, a necroptosis inhibitor by LC-MS/MS and the study of its pharmacokinetics and bioavailabilityFang Geng, Hang Yin, Zhe Li, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|February 12, 2018
Astragalus polysaccharide enhanced antitumor effects of Apatinib in gastric cancer AGS cells by inhibiting AKT signalling pathwayJun Wu, Junxian Yu, Jing Wang, et al.
Pageof 4